Do you consider the clinical considerations when selecting an imaging agent for patients with known or suspected SSTR-positive NETs? Do you know that selecting the right imaging agent can help to identify tumor location, tumor burden, and understand the impact on patient disease course? In this one-hour webinar, Dr. Aman Chauhan and Dr. Riham El Khouli will discuss the difficulties of diagnosing and detecting NETs, and how properties of different imaging agents can affect patient access and imaging accuracy. They will be sharing their clinical experience comparing imaging agents and their use in different clinical situations, as well as showing how the sensitivity and specificity of Detectnet can help to understand the totality of the tumor burden in patient case studies